• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD (SUZHOU) BD SAF-T-INTIMA¿ IV CATHETER SAFETY SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD (SUZHOU) BD SAF-T-INTIMA¿ IV CATHETER SAFETY SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383322
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Extravasation (1842)
Event Date 08/09/2023
Event Type  Injury  
Manufacturer Narrative
B.3.Date of event: unknown.The date received by manufacturer has been used for this field.H.3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that extravasation occurred with the bd saf-t-intima¿ iv catheter safety system during use, causing swelling at the injection site.No further information was provided.This complaint was created to capture the 2nd of 3 related incidents.The following information was provided by the initial reporter: "customer has received defective product that didn't work with the patient & give the results as it should.They compared it with another lot number they had & it worked for the patients & gave the correct results.They have only opened 1 bx, 6 ea left, and 3 bx are in the original packaging & unopened.Additional info from customer: (b)(6) 2023 -can you describe more on the defects found on the product? multiple iv¿s infiltrated with this catheter lot # and have been very few previously.Iv¿s were done with other product, and exam completed without infiltration.-is there any adverse event or serious injury happened? patients had swollen injection sites as it does with infiltration, and patient complaints.1.-what is the occurrence number? to my knowledge, no visible defect in the catheter itself as far as the materials/appearance 2.While using the catheters from that lot number, 3 of our patients had an iv extravagate in one weeks¿ time, two different nurses using same product with same lot number 3.3 patients, 3 catheters within 5 days 4.Unsure of specific dates".
 
Event Description
It was reported that extravasation occurred with the bd saf-t-intima¿ iv catheter safety system during use, causing swelling at the injection site.No further information was provided.This complaint was created to capture the 2nd of 3 related incidents.The following information was provided by the initial reporter: "customer has received defective product that didn't work with the patient & give the results as it should.They compared it with another lot number they had & it worked for the patients & gave the correct results.They have only opened 1 bx, 6 ea left, and 3 bx are in the original packaging & unopened.Additional info from customer: on (b)(6) 2023).Can you describe more on the defects found on the product? multiple iv¿s infiltrated with this catheter lot# and have been very few previously.Iv¿s were done with other product, and exam completed without infiltration.Is there any adverse event or serious injury happened? patients had swollen injection sites as it does with infiltration, and patient complaints.1.What is the occurrence number? to my knowledge, no visible defect in the catheter itself as far as the materials/appearance.2.While using the catheters from that lot number, 3 of our patients had an iv extravagant in one weeks¿ time, two different nurses using same product with same lot number.3.3 patients, 3 catheters within 5 days.4.Unsure of specific dates.".
 
Manufacturer Narrative
H.6.Investigation summary: a device history review was conducted for lot number: 2259638.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Additionally, a sample could not be obtained for evaluation and testing, but this lot was treated and received a certificate of conformance for sterility.Unfortunately, without the ability to investigate the affected unit our quality engineers were unable to determine the root cause for this complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD SAF-T-INTIMA¿ IV CATHETER SAFETY SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
Manufacturer (Section G)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
Manufacturer Contact
jennifer suh
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17628574
MDR Text Key322019184
Report Number3014704491-2023-00485
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903833221
UDI-Public00382903833221
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K923702
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number383322
Device Lot Number2259638
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/09/2023
Initial Date FDA Received08/25/2023
Supplement Dates Manufacturer Received09/29/2023
Supplement Dates FDA Received10/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-